Discover 159 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 159
A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
for
Schizophrenia
Location: Rogers AR, Little Rock AR, Richardson TX, Austin TX,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18 - 65
Code: NCT06894212
Phase3, Recruiting
Efficacy of PP-01 in Mitigating Cannabis Withdrawal Symptoms in Adults With Cannabis Use Disorder
for
Cannabis Withdrawal
Location: Rogers AR, Little Rock AR, Houston TX, Austin TX,
Sponsor: PleoPharma, Inc.
Sex: All
Age: 18 - 55
Code: NCT07644052
Phase3, Recruiting
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
for
Schizophrenia
Location: Rogers AR, Little Rock AR, Richardson TX, DeSoto TX,
Sponsor: MapLight Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07459647
Phase2, Recruiting
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
for
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder,
Location: Rogers AR, Little Rock AR, Memphis TN, O'Fallon MO,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07172516
Phase3, Recruiting
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
for
Bipolar Disorder Type I With Mania or Mania With Mixed Features
Location: Rogers AR, Little Rock AR, Richardson TX, St Louis MO,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18 - 65
Code: NCT06951711
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Springdale AR, Little Rock AR, Kansas City MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Springdale AR, St Louis MO, Dallas TX, Des Moines IA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase3, Recruiting
BostonGene and Exigent Genomic INsight Study
for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Rogers AR, Tulsa OK, Houston TX, Fort Wayne IN,
Sponsor: BostonGene
Sex: All
Age: 18+
Code: NCT06272864
Recruiting
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
for
Advanced Solid Tumor, PDAC, HNSCC
Location: Rogers AR, St Louis MO, Houston TX, San Antonio TX,
Sponsor: Adcendo ApS
Sex: All
Age: 18+
Code: NCT06597721
Phase1, Recruiting
Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo
for
Acne Vulgaris
Location: Rogers AR, Bryant AR, Oklahoma City OK, Louisville KY,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 9 - 11
Code: NCT07524946
Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
for
Schizophrenia
Location: Rogers AR, Bentonville AR, Little Rock AR,
Sponsor: Reviva Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT05184335
Phase3, Recruiting
New
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
for
Schizophrenia
Location: Bentonville AR, Little Rock AR, Richardson TX,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 18 - 65
Code: NCT07686263
Phase3, Recruiting
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.
for
Bipolar I Disorder
Location: Bentonville AR, Little Rock AR, Richardson TX,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07494305
Phase2, Recruiting
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
for
Schizophrenia
Location: Bentonville AR, Little Rock AR, St Louis MO, Chicago IL,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07363577
Phase3, Recruiting
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
for
Major Depressive Disorder
Location: Bentonville AR, Bryant AR, Oklahoma City OK,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07076407
Phase3, Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Rogers AR, Oklahoma City OK, Fort Worth TX, Jackson MS,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase2, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fort Smith AR, Little Rock AR, Jonesboro AR, Olathe KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Fort Smith AR, Branson MO, Joplin MO, Springfield MO,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase3, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Fort Smith AR, Joplin MO, Springfield MO, Tulsa OK,